MCID: HMN036
MIFTS: 54

Hemangiopericytoma, Malignant

Categories: Cancer diseases, Rare diseases

Aliases & Classifications for Hemangiopericytoma, Malignant

MalaCards integrated aliases for Hemangiopericytoma, Malignant:

Name: Hemangiopericytoma, Malignant 58 12 74
Hemangiopericytoma 12 77 54 56 45 15 74
Solitary Fibrous Tumor 60 74
Haemangiopericytic Meningioma 12
Malignant Hemangiopericytoma 12

Characteristics:

Orphanet epidemiological data:

60
solitary fibrous tumor
Inheritance: Not applicable; Age of onset: All ages; Age of death: any age;

OMIM:

58
Inheritance:
autosomal recessive


HPO:

33
hemangiopericytoma, malignant:
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:264
OMIM 58 234820
MeSH 45 D006393
NCIt 51 C3087
SNOMED-CT 69 36060005
MESH via Orphanet 46 D006393
ICD10 via Orphanet 35 D21.9
UMLS via Orphanet 75 C0018922 C1266119
Orphanet 60 ORPHA2126
MedGen 43 C0334542
SNOMED-CT via HPO 70 258211005 49601007

Summaries for Hemangiopericytoma, Malignant

NIH Rare Diseases : 54 Hemangiopericytoma is a term used to described a group of tumors that are derived from pericytes, the cells normally arranged along specific types of blood vessels called capillaries and venules. These types of tumors are typically slow-growing, may be either benign (non-cancerous) or malignant (cancerous), and may occur anywhere in the body.

MalaCards based summary : Hemangiopericytoma, Malignant, also known as hemangiopericytoma, is related to meninges hemangiopericytoma and secretory meningioma. An important gene associated with Hemangiopericytoma, Malignant is STAT6 (Signal Transducer And Activator Of Transcription 6), and among its related pathways/superpathways are ERK Signaling and Cytoskeletal Signaling. The drugs Mechlorethamine and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include liver, kidney and lung, and related phenotypes are abnormality of the cardiovascular system and Reduced mammosphere formation

Disease Ontology : 12 A soft tissue cancer that is a soft tissue sarcoma and originates in the pericytes in the walls of capillaries.

Wikipedia : 77 A hemangiopericytoma is a type of soft tissue sarcoma that originates in the pericytes in the walls of... more...

Description from OMIM: 234820

Related Diseases for Hemangiopericytoma, Malignant

Diseases in the Hemangiopericytoma, Malignant family:

Adult Malignant Hemangiopericytoma

Diseases related to Hemangiopericytoma, Malignant via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 289)
# Related Disease Score Top Affiliating Genes
1 meninges hemangiopericytoma 33.9 IGF2 STAT6 VIM
2 secretory meningioma 31.1 MUC1 VIM
3 meningioma, familial 30.9 IGF2 NAB2 STAT6
4 glomus tumor 30.6 ACTC1 DES VIM
5 infantile myofibromatosis 30.6 ACTC1 DES VIM
6 liposarcoma 30.3 DES MDM2 VIM
7 spindle cell lipoma 30.3 ACTC1 DES MDM2 VIM
8 intravascular papillary endothelial hyperplasia 30.3 ACTC1 VIM
9 endometrial stromal sarcoma 30.2 ACTC1 DES VIM
10 pseudosarcomatous fibromatosis 30.2 ACTC1 DES VIM
11 adenofibroma 30.2 ACTC1 MUC1 VIM
12 fasciitis 30.2 ACTC1 DES MUC1
13 angiosarcoma 30.2 MUC1 PECAM1 VIM
14 sarcoma, synovial 30.1 DES MDM2 MUC1 VIM
15 dedifferentiated liposarcoma 30.1 ACTC1 DES MDM2 STAT6
16 malignant triton tumor 30.1 DES S100B
17 myoepithelioma 30.0 ACTC1 S100B VIM
18 mesenchymal chondrosarcoma 30.0 DES MUC1 VIM
19 muscle cancer 29.9 DES IGF2 MDM2
20 monophasic synovial sarcoma 29.9 MUC1 S100B VIM
21 fibrous meningioma 29.8 F13A1 MUC1 S100B VIM
22 leiomyoma 29.8 ACTC1 DES IGF2 VIM
23 neurofibroma 29.8 F13A1 MUC1 S100B
24 pleomorphic adenoma 29.7 ACTC1 MDM2 MUC1 S100B VIM
25 chordoma 29.6 DES MUC1 S100B VIM
26 fibrous histiocytoma 29.6 ACTC1 DES F13A1 S100B VIM
27 gastrointestinal stromal tumor 29.4 ACTC1 DES IGF2 S100B VIM
28 neurilemmoma 29.4 DES NGFR S100B VIM
29 cutaneous fibrous histiocytoma 29.4 ACTC1 DES F13A1 S100B VIM
30 dermatofibrosarcoma protuberans 29.4 ACTC1 DES F13A1 S100B VIM
31 spindle cell sarcoma 29.1 ACTC1 DES MDM2 MUC1 S100B VIM
32 malignant pleural solitary fibrous tumor 12.5
33 malignant peritoneal solitary fibrous tumor 12.4
34 breast hemangiopericytoma 12.3
35 kidney hemangiopericytoma 12.3
36 retroperitoneal hemangiopericytoma 12.3
37 conventional malignant hemangiopericytoma 12.1
38 adult malignant hemangiopericytoma 12.1
39 benign fibrous mesothelioma 11.6
40 liver fibroma 11.4
41 desmoid tumor 11.3
42 heart malignant hemangiopericytoma 11.2
43 malignant mediastinum hemangiopericytoma 11.2
44 adult intracranial malignant hemangiopericytoma 11.2
45 childhood malignant hemangiopericytoma 11.2
46 hypoglycemia 10.5
47 potter's syndrome 10.5
48 lymphangiectasis 10.4 ACTC1 VIM
49 glomangiomyoma 10.4 ACTC1 VIM
50 spinal meningioma 10.4

Graphical network of the top 20 diseases related to Hemangiopericytoma, Malignant:



Diseases related to Hemangiopericytoma, Malignant

Symptoms & Phenotypes for Hemangiopericytoma, Malignant

Human phenotypes related to Hemangiopericytoma, Malignant:

33
# Description HPO Frequency HPO Source Accession
1 abnormality of the cardiovascular system 33 HP:0001626

Symptoms via clinical synopsis from OMIM:

58
Vascular:
malignant hemangiopericytoma

Clinical features from OMIM:

234820

GenomeRNAi Phenotypes related to Hemangiopericytoma, Malignant according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.1 ACTG2 DES F13A1 IGF2 MDM2 VIM

MGI Mouse Phenotypes related to Hemangiopericytoma, Malignant:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.02 ACTC1 DES F13A1 HACL1 IGF2 MDM2
2 homeostasis/metabolism MP:0005376 10 ACTC1 DES F13A1 IGF2 MDM2 NAB2
3 cellular MP:0005384 9.97 ACTC1 DES IGF2 MDM2 NAB2 NGFR
4 liver/biliary system MP:0005370 9.63 IGF2 MDM2 NAB2 NGFR PECAM1 STAT6
5 muscle MP:0005369 9.5 ACTC1 DES IGF2 MDM2 NGFR PECAM1
6 respiratory system MP:0005388 9.17 F13A1 IGF2 NAB2 NGFR PECAM1 STAT6

Drugs & Therapeutics for Hemangiopericytoma, Malignant

Drugs for Hemangiopericytoma, Malignant (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 55)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1 51-75-2 4033
2
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Lenograstim Approved, Investigational Phase 3,Phase 2 135968-09-1
5
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 38904 498142
6
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
7
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
8
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
9
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
10
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
13 Alkylating Agents Phase 3,Phase 2,Phase 1
14 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
15 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
16 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
17 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
18
Isophosphamide mustard Phase 3,Phase 2,Phase 1 0
19 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
20 Immunologic Factors Phase 3,Phase 2
21 Etoposide phosphate Phase 3,Phase 2
22 Antirheumatic Agents Phase 3,Phase 2,Phase 1
23 Antimitotic Agents Phase 3,Phase 2
24 Anti-Infective Agents Phase 3,Phase 2
25 Immunosuppressive Agents Phase 3,Phase 2
26 Antineoplastic Agents, Phytogenic Phase 3,Phase 2
27
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
28
Axitinib Approved, Investigational Phase 2 319460-85-0 6450551
29
Bevacizumab Approved, Investigational Phase 2 216974-75-3
30
Romidepsin Approved, Investigational Phase 2 128517-07-7 5352062
31
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
32
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
33
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
34
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
35
Vatalanib Investigational Phase 2 212141-54-3 151194
36 Soblidotin Investigational Phase 2 149606-27-9
37
Camptothecin Experimental Phase 2 7689-03-4
38 Exatecan Investigational Phase 2 171335-80-1
39 Protein Kinase Inhibitors Phase 2,Phase 1
40 Angiogenesis Modulating Agents Phase 2
41 Antineoplastic Agents, Immunological Phase 2
42 Angiogenesis Inhibitors Phase 2
43 Immunoglobulins Phase 2
44 Antibodies Phase 2
45 Antibodies, Monoclonal Phase 2
46 Imatinib Mesylate Phase 1, Phase 2 220127-57-1 123596
47 topoisomerase I inhibitors Phase 2
48
Celecoxib Approved, Investigational Phase 1 169590-42-5 2662
49 Anti-Inflammatory Agents Phase 1
50 Analgesics Phase 1

Interventional clinical trials:

(show all 35)
# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
3 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Completed NCT00423618 Phase 3
4 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
5 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
6 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
7 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
8 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
9 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
10 Phase II Study on Axitinib in Advanced Solitary Fibrous Tumor Unknown status NCT02261207 Phase 2 Axitinib
11 Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma Unknown status NCT02066285 Phase 2 Pazopanib
12 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
13 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
14 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed NCT00348790 Phase 2 vatalanib
15 S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Completed NCT00217620 Phase 2 sorafenib
16 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
17 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
18 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
19 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
20 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
21 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
22 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
23 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
24 Trial of Dasatinib in Advanced Sarcomas Completed NCT00464620 Phase 2 Dasatinib
25 Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor Recruiting NCT03023124 Phase 2 Trabectedin;Adriamycin;Dacarbazine
26 Eribulin in Advanced Solitary Fibrous Tumor Not yet recruiting NCT03840772 Phase 2 Eribulin
27 S9624 Ifosfamide in Treating Patients With Meningeal Tumors Terminated NCT00003292 Phase 2 ifosfamide
28 Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma Terminated NCT00740597 Phase 2
29 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Completed NCT00450736 Phase 1 celecoxib
30 Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00030784 Phase 1 ifosfamide;pegylated liposomal doxorubicin hydrochloride
31 Tissue Sample Collection From Patients With Soft Tissue Sarcoma of the Arms, Hands, Legs, or Feet Treated on Clinial Trial CRUK-VORTEX Unknown status NCT00900211
32 Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura. Unknown status NCT01694654
33 Staging Procedures to Diagnose Malignant Pleural Mesothelioma Recruiting NCT02648763
34 Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma Recruiting NCT02613312
35 Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma Recruiting NCT02613299

Search NIH Clinical Center for Hemangiopericytoma, Malignant

Cochrane evidence based reviews: hemangiopericytoma

Genetic Tests for Hemangiopericytoma, Malignant

Anatomical Context for Hemangiopericytoma, Malignant

MalaCards organs/tissues related to Hemangiopericytoma, Malignant:

42
Liver, Kidney, Lung, Bone, Breast, Thyroid, Tongue

Publications for Hemangiopericytoma, Malignant

Articles related to Hemangiopericytoma, Malignant:

(show top 50) (show all 1829)
# Title Authors Year
1
Synchronous Pulmonary Adenofibroma and Solitary Fibrous Tumor: Case Report and Review of the Literature. ( 30360665 )
2019
2
Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma. ( 30777209 )
2019
3
Solitary Fibrous Tumor of the Urinary Bladder Associated with Hypoglycemia: An Unusual Case of Doege-Potter Syndrome. ( 31039567 )
2019
4
Successful Multimodal Treatment of an IGF2-Producing Solitary Fibrous Tumor With Acromegaloid Changes and Hypoglycemia. ( 30788455 )
2019
5
Retroperitoneal Pelvic Solitary Fibrous Tumor With High Tracer Uptake in 68Ga-DOTATOC PET/CT: A Rare Differential Diagnosis of Paraganglioma. ( 30888990 )
2019
6
Solitary fibrous tumor mimicking adrenal tumor concomitant with contralateral adrenal pheochromocytoma: A case report of surgical resection after long-term observation. ( 31055127 )
2019
7
Fat-forming variant of solitary fibrous tumor of the pleura, mimicking spindle cell lipoma. ( 30983082 )
2019
8
Apparent diffusion coefficient values in differential diagnosis and prognostic prediction of solitary of fibrous tumor/hemangiopericytoma (WHOII) and atypical meningioma. ( 30664513 )
2019
9
Solitary fibrous tumor of the pleura with Doege-Potter syndrome: Second recurrence in a 93-year-old female. ( 30719313 )
2019
10
A solitary fibrous tumor in the pelvic cavity of a patient with Doege-Potter syndrome: a case report. ( 30976927 )
2019
11
A rapidly fatal intracranial anaplastic hemangiopericytoma with de-novo dedifferentiation: emphasis on diagnostic recognition, molecular confirmation and discussion on treatment dilemma. ( 30603845 )
2019
12
Hemangiopericytoma of Gingiva in a 4-Year-Old Child: A Rare Case Report. ( 30728692 )
2019
13
Coexistence of intracranial solitary fibrous tumor/hemangiopericytoma and right middle cerebral artery aneurysm. ( 30740209 )
2019
14
18F-Choline PET/CT Imaging for Intracranial Hemangiopericytoma Recurrence. ( 30762828 )
2019
15
A case of solitary fibrous tumor/hemangiopericytoma in the central nervous system with papillary morphology. ( 30864263 )
2019
16
Frozen Cytology of Meningeal Malignant Solitary Fibrous Tumor/Hemangiopericytoma. ( 30971071 )
2019
17
SPINE METASTASIS OF INTRACRANIAL HEMANGIOPERICYTOMA: CASE REPORT OF TWO TREATMENTS. ( 30988657 )
2019
18
Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system. ( 31054100 )
2019
19
Primary Intraparenchymal Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma Presenting with Intracerebral Hemorrhage: A Case Report. ( 31062533 )
2019
20
Congenital vaginal hemangiopericytoma: a rare fetal tumor. ( 29573489 )
2019
21
Renal solitary fibrous tumor/hemangiopericytoma: computed tomography findings and clinicopathologic features. ( 30225611 )
2019
22
Primary epidural hemangiopericytoma of the thoracic spine: Case report and literature review. ( 30352760 )
2019
23
Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma. ( 30371551 )
2019
24
A Case Report of Meningeal Hemangiopericytoma: A 9-Year Journey from the Brain to the Spine. ( 30447454 )
2019
25
Solitary fibrous tumor/hemangiopericytoma of the optic canal. ( 30499771 )
2019
26
Intraspinal Dissemination and Local Recurrence of an Intracranial Hemangiopericytoma. ( 30503286 )
2019
27
Solitary fibrous tumor of the lumbar spine resembling schwannoma: a case report and review of the literature. ( 30654157 )
2019
28
Imaging an intrapulmonary solitary fibrous tumor with CT and F-18 FDG PET/CT. ( 30992735 )
2019
29
Pericardial Solitary Fibrous Tumor on FDG PET/CT. ( 30371588 )
2019
30
Tumor-to-tumor metastasis of lung adenocarcinoma into a spinal intradural solitary fibrous tumor: a case report. ( 30315364 )
2018
31
Preoperative Prediction of Solitary Fibrous Tumor/Hemangiopericytoma and Angiomatous Meningioma Using Magnetic Resonance Imaging Texture Analysis. ( 30240864 )
2018
32
Metastatic craniocervical hemangiopericytoma presenting with hydrocephalus and papilledema - Case review. ( 30318074 )
2018
33
Overexpression of IGF2 and IGF2 receptor in malignant solitary fibrous tumor with hypoglycemia: a case report. ( 30168002 )
2018
34
Metastatic Solitary Fibrous Tumor With Doege-Potter Syndrome: Hypoglycemia Treated by 90Y Radioembolization. ( 29293132 )
2018
35
An intravascular papillary endothelial hyperplasia of the hand radiologically mimicking a hemangiopericytoma: A case report and literature review. ( 29348916 )
2018
36
Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report. ( 30593185 )
2018
37
Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma. ( 29340167 )
2018
38
Late Onset of Non-islet Cell Tumor Hypoglycemia Managed via Multidisciplinary Treatment in a Patient with a Solitary Fibrous Tumor. ( 29526941 )
2018
39
Very rare localization of a retroperitoneal hemangiopericytoma revealed by lumbosciatalgia: A case report. ( 30391737 )
2018
40
Solitary Fibrous Tumor of the Tongue: An Uncommon Cause of Obstructive Sleep Apnea. ( 30344384 )
2018
41
Diffusion weighted imaging may help differentiate intracranial hemangiopericytoma from meningioma. ( 30500359 )
2018
42
Preoperative Assessment of Pathologic Subtypes of Meningioma and Solitary Fibrous Tumor/Hemangiopericytoma Using Dynamic Computed Tomography: A Clinical Research Study. ( 29709742 )
2018
43
Value of SSTR2A and Claudin - 1 in Differentiating Meningioma from Schwannoma and Hemangiopericytoma. ( 29531582 )
2018
44
A broad ligament solitary fibrous tumor with Doege-Potter syndrome. ( 30278559 )
2018
45
Unedited microneurosurgery of a solitary fibrous tumor of the pineal region. ( 30595953 )
2018
46
Malignant Solitary Fibrous Tumor Metastatic to Widely Invasive Hurthle Cell Thyroid Carcinoma: A Distinct Tumor-to-Tumor Metastasis. ( 29616597 )
2018
47
Diagnosis and treatment of hemangiopericytoma in the central nervous system. ( 30589042 )
2018
48
Rare Occurrence of an Intraocular Choroidal Solitary Fibrous Tumor/Hemangiopericytoma. ( 30643764 )
2018
49
Infantile hemangiopericytoma of the tongue-Efficacy of ex utero intrapartum treatment procedure and combined-modality therapy. ( 28365065 )
2018
50
Recurrent primary osseous hemangiopericytoma in the thoracic spine: a case report and literature review. ( 28993889 )
2018

Variations for Hemangiopericytoma, Malignant

Cosmic variations for Hemangiopericytoma, Malignant:

9 (show all 19)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM7335402 SF3B1 soft tissue,blood vessel,other,benign c.2014G>T p.A672S 2:197402619-197402619 0
2 COSM584 NRAS soft tissue,blood vessel,haemangioma,capillary c.182A>G p.Q61R 1:114713908-114713908 0
3 COSM580 NRAS soft tissue,blood vessel,haemangioma,capillary c.181C>A p.Q61K 1:114713909-114713909 0
4 COSM7335401 NCOR1 soft tissue,blood vessel,other,benign c.3838G>T p.G1280W 17:16072202-16072202 0
5 COSM7335404 MSH6 soft tissue,blood vessel,other,benign c.3215G>A p.G1072D 2:47803462-47803462 0
6 COSM7335403 MAP2K2 soft tissue,blood vessel,other,benign c.979A>G p.N327D 19:4097284-4097284 0
7 COSM529 KRAS soft tissue,blood vessel,haemangioma,capillary c.37G>C p.G13R 12:25245348-25245348 0
8 COSM521 KRAS soft tissue,blood vessel,haemangioma,capillary c.35G>A p.G12D 12:25245350-25245350 0
9 COSM516 KRAS soft tissue,blood vessel,haemangioma,capillary c.34G>T p.G12C 12:25245351-25245351 0
10 COSM487 HRAS soft tissue,blood vessel,haemangioma,capillary c.37G>A p.G13S 11:534286-534286 0
11 COSM6503574 HRAS soft tissue,blood vessel,haemangioma,capillary c.145G>A p.E49K 11:533911-533911 0
12 COSM6503575 HRAS soft tissue,blood vessel,haemangioma,capillary c.44G>A p.G15D 11:534279-534279 0
13 COSM499 HRAS soft tissue,blood vessel,haemangioma,capillary c.182A>G p.Q61R 11:533874-533874 0
14 COSM6503576 HRAS soft tissue,blood vessel,haemangioma,capillary c.100C>T p.P34S 11:534223-534223 0
15 COSM486 HRAS soft tissue,blood vessel,haemangioma,capillary c.37G>C p.G13R 11:534286-534286 0
16 COSM52975 GNAQ soft tissue,blood vessel,haemangioma,capillary c.548G>A p.R183Q 9:77797577-77797577 0
17 COSM21651 GNA11 soft tissue,blood vessel,haemangioma,capillary c.547C>T p.R183C 19:3115014-3115014 0
18 COSM476 BRAF soft tissue,blood vessel,haemangioma,capillary c.1799T>A p.V600E 7:140753336-140753336 0
19 COSM449 BRAF soft tissue,blood vessel,haemangioma,capillary c.1391G>A p.G464E 7:140781617-140781617 0

Expression for Hemangiopericytoma, Malignant

Search GEO for disease gene expression data for Hemangiopericytoma, Malignant.

Pathways for Hemangiopericytoma, Malignant

Pathways related to Hemangiopericytoma, Malignant according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.33 ACTG2 DES IGF2 MDM2 MUC1 NGFR
2 11.84 ACTC1 ACTG2 DES MUC1 VIM
3 11.19 ACTC1 DES VIM
4 10.98 F13A1 MUC1 STAT6 VIM

GO Terms for Hemangiopericytoma, Malignant

Cellular components related to Hemangiopericytoma, Malignant according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 blood microparticle GO:0072562 8.8 ACTC1 ACTG2 F13A1

Biological processes related to Hemangiopericytoma, Malignant according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.71 ACTC1 ACTG2 MDM2 VIM
2 cytokine-mediated signaling pathway GO:0019221 9.56 F13A1 MUC1 STAT6 VIM
3 platelet degranulation GO:0002576 9.5 F13A1 IGF2 PECAM1
4 intermediate filament organization GO:0045109 9.37 DES VIM
5 negative regulation of neuron projection development GO:0010977 9.16 MDM2 VIM
6 mesenchyme migration GO:0090131 8.96 ACTC1 ACTG2
7 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Hemangiopericytoma, Malignant according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.17 DES HACL1 MDM2 NAB2 S100B STAT6

Sources for Hemangiopericytoma, Malignant

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....